Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neurología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
Prospective, Multicenter, Randomized, Double-blind, Parallel-group, Dose-response Study of Three Doses Xeomin® (incobotulinumtoxinA, NT 201) for the Treatment of Upper Limb Spasticity Alone or Combined Upper and Lower Limb Spasticity in Children and Adolescents (Age 2 - 17 Years) With Cerebral Palsy
INTERVENTIONAL
Inicio: 28 de mar de 2014
ID: NCT02002884
Completado
ClinicalTrials.gov
An Analysis of Mortality in Subjects Who Participated in Three Studies of Galantamine in Mild Cognitive Impairment
OBSERVATIONAL
Inicio: 1 de jun de 2004
ID: NCT00297414
Reclutando
ClinicalTrials.gov
Comparative Analysis of Diet and Cardiometabolic Health in Individuals Following Vegan, Vegetarian, and Omnivorous Diets in the City of Rosario
OBSERVATIONAL
Inicio: 1 de dic de 2025
ID: NCT07247487
Completado
Fase 3
ClinicalTrials.gov
Double-blind Extension of the Study 27025 (REFLEX) to Obtain Long-term Follow-up Data in Patients With Clinically Definite MS and Patients With a First Demyelinating Event at High Risk of Converting to MS, Treated With Rebif® New Formulation (REFLEXION)
INTERVENTIONAL
Inicio: 1 de dic de 2008
ID: NCT00813709
Reclutando
ClinicalTrials.gov
NeuroVascular Product Surveillance Registry (PSR) Platform
OBSERVATIONAL
Inicio: 1 de dic de 2016
ID: NCT02988128
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing SAR442168 to Placebo in Participants With Primary Progressive Multiple Sclerosis (PERSEUS)
INTERVENTIONAL
Inicio: 13 de ago de 2020
ID: NCT04458051
Reclutando
Fase 2
ClinicalTrials.gov
A Phase II, Randomized, Open-label, Parallel Group, Multicenter Study to Assess Bioequivalence of Two Subcutaneous Formulations of Ocrelizumab in Patients With Multiple Sclerosis
INTERVENTIONAL
Inicio: 13 de nov de 2025
ID: NCT07074886
Completado
Fase 4
ClinicalTrials.gov
A Multicenter, Single-arm, Open-label, Postmarketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure
INTERVENTIONAL
Inicio: 25 de sept de 2013
ID: NCT01977651
Completado
Fase 4
ClinicalTrials.gov
A Multicenter, Prospective, Randomized, Open-label, Blinded-endpoint, Phase 4 Study to Evaluate the Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With Chronic Chagas' Cardiomyopathy. The Study is Also Know as Prevention And Reduction of Adverse Outcomes in Chagasic Heart failUre Trial Evaluation (PARACHUTE-HF).
INTERVENTIONAL
Inicio: 10 de dic de 2019
ID: NCT04023227
Terminado
Fase 3
ClinicalTrials.gov
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study of Gantenerumab in Patients With Early (Prodromal to Mild) Alzheimer's Disease
INTERVENTIONAL
Inicio: 22 de ago de 2018
ID: NCT03443973
Completado
Fase 3
ClinicalTrials.gov
Multicenter, Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of IGIV-Chromatography (IGIV-C), 10% Treatment in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy
INTERVENTIONAL
Inicio: 1 de abr de 2004
ID: NCT00220740
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-1)
INTERVENTIONAL
Inicio: 11 de jun de 2025
ID: NCT06951698
Completado
ClinicalTrials.gov
Programme of Diabetes Education in the City of Corrientes (PRODIACOR): Clinical, Metabolic and Economic Outcomes of a Prospective-randomized Trial Based on Different Patient-centered Educational Strategies for People With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de dic de 2006
ID: NCT01456806
Completado
ClinicalTrials.gov
Elaboration, Development and Validation of Predictive Models of Weight and Height for the Evaluation of the Growth of Children and Adolescents With Cerebral Palsy
OBSERVATIONAL
Inicio: 1 de abr de 2014
ID: NCT03303755
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Patients With Influenza A Infection
INTERVENTIONAL
Inicio: 3 de ene de 2018
ID: NCT03376321
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase III Multicenter, Randomized, Double-blind, Double-dummy Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis
INTERVENTIONAL
Inicio: 19 de may de 2022
ID: NCT05123703
Activo, no recluta
Fase 3
ClinicalTrials.gov
An Open-Label, Extension Study to Assess the Long-Term Safety and Efficacy of ION-682884 in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
INTERVENTIONAL
Inicio: 4 de ene de 2022
ID: NCT05071300
Completado
Fase 3
ClinicalTrials.gov
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
INTERVENTIONAL
Inicio: 30 de nov de 2010
ID: NCT01224106
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease
INTERVENTIONAL
Inicio: 26 de sept de 2024
ID: NCT06585787
Completado
Fase 4
ClinicalTrials.gov
A Fixed Dose, Dose-response Study of Ropinirole Prolonged Release (PR) as Adjunctive Treatment to L-dopa in Patients With Advanced Parkinson's Disease
INTERVENTIONAL
Inicio: 2 de abr de 2012
ID: NCT01494532
Anterior
1
...
17
18
19
...
434
Siguiente
Filtros